Proactive therapeutic drug monitoring of adalimumab is associated with better long-term outcomes compared to standard of care in patients with inflammatory bowel disease
Papamichael, Konstantinos, Juncadella, Anna, Wong, Danny, Rakowsky, Shana, Sattler, Lindsey A, Campbell, James P, Vaughn, Byron P, Cheifetz, Adam SJournal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjz018
Date:
January, 2019
File:
PDF, 614 KB
2019